Cargando…

Clinical Differences between Eosinophilic and Noneosinophilic Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Multicenter Cross-Sectional Study

METHODS: A total of 643 AECOPD patients were enrolled in this multicenter cross-sectional study. Finally, 455 were included, 214 in the normal-eosinophil AECOPD (NEOS-AECOPD) group, 63 in the mild increased-eosinophil AECOPD (MEOS-AECOPD) group, and 138 in the severe increased-eosinophil AECOPD (SEO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Guangming, Ran, Yajuan, Wang, Jiajia, Chen, Xingru, Peng, Junnan, Li, Xinglong, Deng, Huojin, Xiao, Min, Zhu, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676927/ https://www.ncbi.nlm.nih.gov/pubmed/33273887 http://dx.doi.org/10.1155/2020/1059079

Ejemplares similares

Risk Factors for Length of Hospital Stay in Acute Exacerbation Chronic Obstructive Pulmonary Disease: A Multicenter Cross-Sectional Study
por: Wang, Hong, et al.
Publicado: (2022)

Machine learning reveals sex differences in clinical features of acute exacerbation of chronic obstructive pulmonary disease: A multicenter cross-sectional study
por: Chen, Zhihong, et al.
Publicado: (2023)

Pulmonary hypertension in eosinophilic versus noneosinophilic COPD
por: Alzghoul, Bashar N., et al.
Publicado: (2021)

534 Clinical Characteristics of Eosinophilic Asthma Compared to Noneosinophilic Asthma in Children
por: Lee, Yong Ju, et al.
Publicado: (2012)

Comparative analysis of inflammatory signature profiles in eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyposis
por: Yao, Yao, et al.
Publicado: (2020)

Transcriptome Analysis Reveals Distinct Gene Expression Profiles in Eosinophilic and Noneosinophilic Chronic Rhinosinusitis with Nasal Polyps
por: Wang, Weiqing, et al.
Publicado: (2016)

High Blood Eosinophil and YKL-40 Levels, as Well as Low CXCL9 Levels, are Associated with Increased Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Peng, Junnan, et al.
Publicado: (2021)

Richness of sputum microbiome in acute exacerbations of eosinophilic chronic obstructive pulmonary disease
por: Qi, Yu-Jing, et al.
Publicado: (2020)

Risk factors for hyponatremia in acute exacerbation chronic obstructive pulmonary disease (AECOPD): a multicenter cross-sectional study
por: Xiao, Min, et al.
Publicado: (2023)

Differences in the lipid metabolism profile and clinical characteristics between eosinophilic and non-eosinophilic acute exacerbation of chronic obstructive pulmonary disease
por: Wang, Yating, et al.
Publicado: (2023)

Blood Eosinophil Count and Hospital Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Hegewald, Matthew J, et al.
Publicado: (2020)

Peripheral Blood Eosinophil as a Biomarker in Outcomes of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Wu, Hong-Xia, et al.
Publicado: (2019)

Eosinophil values in exacerbation and stable chronic obstructive pulmonary disease and its relationship to maintenance therapy in stable chronic obstructive pulmonary disease patients
por: Fachri, Muhammad, et al.
Publicado: (2023)

The association between blood eosinophil percent and bacterial infection in acute exacerbation of chronic obstructive pulmonary disease
por: Choi, Juwhan, et al.
Publicado: (2019)

Blood Eosinophil and Risk of Exacerbation in Chronic Obstructive Pulmonary Disease Patients: A Retrospective Cohort Analysis
por: Chan, Ming Chiu, et al.
Publicado: (2020)

Variability of Blood Eosinophil Count at Stable-State in Predicting Exacerbation Risk of Chronic Obstructive Pulmonary Disease
por: Kwok, Wang Chun, et al.
Publicado: (2023)

The lower the eosinophils, the stronger the inflammatory response? The relationship of different levels of eosinophils with the degree of inflammation in acute exacerbation chronic obstructive pulmonary disease (AECOPD)
por: Lv, Mei-Yu, et al.
Publicado: (2021)

Eosinophilic Chronic Obstructive Pulmonary Disease
por: Weissler, Jonathan C., et al.
Publicado: (2021)

Relationship of Blood Eosinophils with Fractional Exhaled Nitric Oxide and Pulmonary Function Parameters in Chronic Obstructive Pulmonary Disease (COPD) Exacerbation
por: Tang, Bin, et al.
Publicado: (2020)

Elevated Peripheral Blood Eosinophils during Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Prevalence and clinical significance
por: Al Sibani, Maitha, et al.
Publicado: (2022)

Re: Elevated Peripheral Blood Eosinophils during Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Prevalence and clinical significance
por: Okauchi, Shinichiro, et al.
Publicado: (2022)

Blood Eosinophils and Clinical Outcomes in Inpatients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Prospective Cohort Study
por: Pu, Jiaqi, et al.
Publicado: (2023)

Blood Eosinophil Count as a Predictive Biomarker of Chronic Obstructive Pulmonary Disease Exacerbation in a Real-World Setting
por: Komura, Moegi, et al.
Publicado: (2023)

Risk Factors for Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Industrial Regions of China: A Multicenter Cross-Sectional Study
por: Dong, Hongna, et al.
Publicado: (2020)

Exacerbations of Chronic Obstructive Pulmonary Disease
por: Garvey, Christine, et al.
Publicado: (2012)

The Chronic Obstructive Pulmonary Disease Exacerbation
por: Sherk, Peter A., et al.
Publicado: (2000)

Exacerbation of Chronic Obstructive Pulmonary Disease
por: Zhou, Xianghui, et al.
Publicado: (2015)

Association between blood eosinophil count and bacterial infection and clinical outcomes in patients with severe exacerbations of chronic obstructive pulmonary disease
por: Wang, Fei, et al.
Publicado: (2022)

Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy
por: Chen, Stephanie, et al.
Publicado: (2022)

Blood eosinophil count-guided corticosteroid therapy and as a prognostic biomarker of exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis
por: Liu, Tao, et al.
Publicado: (2021)

The association between eosinophilic exacerbation and eosinophilic levels in stable COPD
por: Kang, Hye Seon, et al.
Publicado: (2021)

Mepolizumab in the treatment of eosinophilic chronic obstructive pulmonary disease
por: Mkorombindo, Takudzwa, et al.
Publicado: (2019)

The stability of blood Eosinophils in chronic obstructive pulmonary disease
por: Long, Gabriella H., et al.
Publicado: (2020)

Targeted therapy in eosinophilic chronic obstructive pulmonary disease
por: Fieldes, Mathieu, et al.
Publicado: (2021)

A Multicenter Study to Identify the Respiratory Pathogens Associated with Exacerbation of Chronic Obstructive Pulmonary Disease in Korea
por: Lee, Hyun Woo, et al.
Publicado: (2022)

Shall We Focus on the Eosinophil to Guide Treatment with Systemic Corticosteroids during Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)? CON
por: Marcos, Pedro J, et al.
Publicado: (2018)

Stability of blood eosinophils in acute exacerbation of chronic obstructive pulmonary disease and its relationship to clinical outcomes: a prospective cohort study
por: Cui, Yanan, et al.
Publicado: (2021)

Application Value of Blood Heparin-Binding Protein in the Diagnosis of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Dong, Yuan, et al.
Publicado: (2021)

Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Segal, Leopoldo N., et al.
Publicado: (2015)

Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_5o8jdriv5ahns5sr1ktf14sukg